(5-甲基-2-苯基-2H-1,2,3-噻唑-4-基)甲醇 | 13322-19-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: (5-甲基-2-苯基-2H-1,2,3-噻唑-4-基)甲醇
• 英文名称: (5-methyl-2-phenyl-2H-1,2,3-triazol-4-yl) methanol
• 英文别名: (5-methyl-2-phenyl-2H-[1,2,3]triazol-4-yl)-methanol；(5-methyl-2-phenyl-2H-[1,2,3]triazol-4-yl)methanol；(5-Methyl-2-phenyl-1,2,3-triazol-4-yl)methan-1-ol；(5-methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methanol；(5-methyl-2-phenyltriazol-4-yl)methanol
• CAS: 13322-19-5
• 化学式: C₁₀H₁₁N₃O
• mdl: MFCD02682048
• 分子量: 189.217
• InChiKey: VYHJVMFMRIGUFV-UHFFFAOYSA-N

物化性质

• 熔点：
  75 °C
• 沸点：
  392.0±34.0 °C(Predicted)
• 密度：
  1.23±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  50.9
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090
• 安全说明：
  S24/25

SDS

Name:	(5-Methyl-2-phenyl-2h-1 2 3-triazol-4-yl)methanol 97% Material Safety Data Sheet
Synonym:	5-Hydroxymethyl-4-methyl-2-phenyl-1,2,3-triazol
CAS:	13322-19-5

Section 1 - Chemical Product MSDS Name:(5-Methyl-2-phenyl-2h-1 2 3-triazol-4-yl)methanol 97% Material Safety Data Sheet
Synonym:5-Hydroxymethyl-4-methyl-2-phenyl-1,2,3-triazol

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
13322-19-5	(5-Methyl-2-phenyl-2H-1,2,3-triazol-4-	97%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 13322-19-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 74 - 76 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H11N3O
Molecular Weight: 189.22

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Not available.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 13322-19-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(5-Methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methanol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 13322-19-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 13322-19-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13322-19-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (5-甲基-2-苯基-2H-1,2,3-噻唑-4-基)甲醇 在 三溴化磷 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 生成 4-溴甲基-5-甲基-2-苯基-2H-1,2,3-三唑
  参考文献：
  名称：

  [EN] PYRAZOLE DERIVATIVES
  [FR] DERIVES DE PYRAZOLE

  摘要：

  通用公式（I）表示的化合物，可用作过氧化物酶体增殖物激活受体α/Ϝ激动剂，该化合物的盐，以及任一种的溶剂。 （在公式中，X、Y和Z分别表示氮或碳；m为0至3的整数；n为1至3的整数；Q表示苯环，可选择地由羟基，卤素，较低烯基，较低烷氧基，较低烷基和氨基取代；R1表示苯基，萘基或可选择地由羟基，卤素，较低烯基，较低烷氧基，苯氧基，苯基，较低烷基和氨基取代的5-或6-成员芳香杂环基；R2表示较低烷基，氨基甲酰基，苯基或5-或6-成员芳香杂环基；R3和R4分别表示氢或较低烷基；R5表示氢，较低烷基或苄基；R6表示氢，羟基，卤素，较低烯基，较低烷氧基，苯氧基，苯基，较低烷基或氨基

  公开号：

  WO2006013939A1
• 作为产物：
  描述：

  甲基-2-苯基-1,2,3-三唑-5-羧酸 在 dimethyl sulfide borane 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 生成 (5-甲基-2-苯基-2H-1,2,3-噻唑-4-基)甲醇
  参考文献：
  名称：

  [EN] PYRAZOLE DERIVATIVES
  [FR] DERIVES DE PYRAZOLE

  摘要：

  通用公式（I）表示的化合物，可用作过氧化物酶体增殖物激活受体α/Ϝ激动剂，该化合物的盐，以及任一种的溶剂。 （在公式中，X、Y和Z分别表示氮或碳；m为0至3的整数；n为1至3的整数；Q表示苯环，可选择地由羟基，卤素，较低烯基，较低烷氧基，较低烷基和氨基取代；R1表示苯基，萘基或可选择地由羟基，卤素，较低烯基，较低烷氧基，苯氧基，苯基，较低烷基和氨基取代的5-或6-成员芳香杂环基；R2表示较低烷基，氨基甲酰基，苯基或5-或6-成员芳香杂环基；R3和R4分别表示氢或较低烷基；R5表示氢，较低烷基或苄基；R6表示氢，羟基，卤素，较低烯基，较低烷氧基，苯氧基，苯基，较低烷基或氨基

  公开号：

  WO2006013939A1

文献信息

• [EN] TRIAZOLOPYRIDINE AND TRIAZOLOPYRIMIDINE INHIBITORS OF MYELOPEROXIDASE<br/>[FR] INHIBITEURS DE MYÉLOPEROXYDASE DE TYPE TRIAZOLOPYRIDINE ET TRIAZOLOPYRIMIDINE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2016040417A1

  公开（公告）日：2016-03-17

  The present invention provides compounds of Formula (I): wherein A and R1 are each as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, which may be used as medicaments.

  本发明提供了式（I）的化合物：其中A和R1如规范中所定义，并包括任何此类新化合物的组合物。这些化合物是髓过氧化物酶（MPO）抑制剂和/或嗜酸性粒细胞过氧化物酶（EPX）抑制剂，可用作药物。
• SUBSTITUTED PYRAZOLE DERIVATIVES
  申请人：ITO Mitsuhiro

  公开号：US20090270359A1

  公开（公告）日：2009-10-29

  The present invention provides a novel pyrazole derivative and an androgen receptor antagonist containing the derivative. The present invention provides a compound represented by the formula (I′) wherein R 1 is a hydrogen atom, a group via a carbon atom, a group via a nitrogen atom, a group via an oxygen atom, or a group via a sulfur atom; R 2 is a phenyl group having cyano (the phenyl group may further have substituent(s) other than cyano); R 3 is a hydrogen atom, a group via a carbon atom, a group via a nitrogen atom, a group via an oxygen atom, or a group via a sulfur atom; R 4 is a cyclic group optionally having substituent(s); and X is methylene optionally having substituent(s), or CO, or a salt thereof.

  本发明提供一种新型吡唑衍生物和含有该衍生物的雄激素受体拮抗剂。本发明提供一种由下式表示的化合物(I′)：其中R1是氢原子、通过碳原子的基团、通过氮原子的基团、通过氧原子的基团或通过硫原子的基团；R2是苯基，带有氰基（苯基可能还有除氰基之外的取代基）；R3是氢原子、通过碳原子的基团、通过氮原子的基团、通过氧原子的基团或通过硫原子的基团；R4是可选地带有取代基的环状基团；X是亚甲基，可选地带有取代基，或CO，或其盐。
• Acrylonitrile compounds
  申请人：Nissan Chemical Industries, Ltd.

  公开号：US06642234B1

  公开（公告）日：2003-11-04

  The present invention relates to acrylonitrile compounds of formula (1): [wherein, R is a C1-C6 alkyl, a C3-C7 cycloalkyl optionally substituted by a C1-C4 alkyl, a naphthyl, etc., R1 is H, a halogen, a C1-C6 alkyl, etc., A is specific 5-membered aromatic heterocyclic ring containing two hetero atoms selected from N, O and S, etc., B is H, a C1-C4 alkyl, a C2-C4 alkoxyalkyl, etc.] Said compounds are useful as agricultural chemicals, in particular insecticides and acaricides.

  本发明涉及式（1）的丙烯腈化合物：[其中，R是C1-C6烷基，C3-C7环烷基，可选地被C1-C4烷基取代，萘基等；R1是H，卤素，C1-C6烷基等；A是具有两个异原子（选自N，O和S等）的特定5-成员芳香杂环环，B是H，C1-C4烷基，C2-C4烷氧基烷基等。]所述化合物可用作农药，特别是杀虫剂和杀螨剂。
• “Double-Click” Protocol for Synthesis of Heterobifunctional Multivalent Ligands: Toward a Focused Library of Specific Norovirus Inhibitors
  作者：Julie Guiard、Brigitte Fiege、Pavel I. Kitov、Thomas Peters、David R. Bundle

  DOI：10.1002/chem.201003414

  日期：2011.6.27

  Click, click, hooray! A convenient “double‐click” protocol for the conjugation of two different ligands to multivalent scaffolds was developed. The protocol involves activation of the second attachment site as an azide for the second click reaction (see scheme). This method was used to synthesize potent inhibitors for norovirus‐like particles.

  单击，单击，万岁！开发了一种方便的“双击”方案，用于将两个不同的配体缀合到多价支架上。该方案涉及激活第二个连接位点，作为第二单击反应的叠氮化物（请参阅方案）。该方法用于合成诺如病毒样颗粒的有效抑制剂。
• Substituted arylalkanoic acid derivatives and use thereof
  申请人：Shoda Motoshi

  公开号：US20070213333A1

  公开（公告）日：2007-09-13

  A compound represented by the formula (I): [In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C 2 to C 6 in the aromatic ring (E) independently represent a ring-constituting carbon atom, one of the ring-constituting carbon atoms may be replaced with V, V represents nitrogen atom, or carbon atom substituted with Zx, Zx represents a saturated alkyl group having 1 to 4 carbon atoms and the like, Rs represents -D-Rx etc., D represents a single bond, oxygen atom and the like, Rx represents a saturated alkyl group having 3 to 8 carbon atoms and the like, AR represents a partially unsaturated or completely unsaturated condensed bicyclic carbon ring or a heterocyclic ring, and Y represents hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms and the like] or a salt thereof. A compound having prostaglandin production-suppressing action and leukotriene production-suppressing action is provided.

  化合物的化学式为（I）：[在公式中，Link代表饱和或不饱和的直链碳氢链，其具有1至3个碳原子，C2至C6在芳环（E）中独立地表示构成环的碳原子，构成环的碳原子中的一个可以被V取代，V代表氮原子，或被Zx取代的碳原子，Zx代表饱和的烷基基团，其具有1至4个碳原子等，Rs代表-D-Rx等，D代表单键，氧原子等，Rx代表饱和的烷基基团，其具有3至8个碳原子等，AR代表部分不饱和或完全不饱和的紧凑双环碳环或杂环，Y代表氢原子，具有1至4个碳原子的低烷基基团等]或其盐。提供了一种具有前列腺素生成抑制作用和白三烯生成抑制作用的化合物。